Catalyst Wire Dossier Catalyst Wire Dossier

ARIPIPRAZOLE ORAL

Aripiprazole · Camber Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARIPIPRAZOLE ORAL, covering 2014-01-16 to 2023-11-01. Get the full timeline:

Most recent: FDA Approved: ARIPIPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)

See pricing